Formulation and In-vivo Evaluation of Azatanavir Selfnanoemulsifying Drug Delivery System
Abstract
Atazanavir is a human immunodeficiency virus (HIV) protease inhibitor. Due to its intense lipophilicity, the oral delivery of atazanavir encounters several problems such as poor aqueous solubility, pH-dependent dissolution and rapid first-pass metabolism in liver by CYP3A5, which result in low and erratic bioavailability. The current study aimed to develop self-nanoemulsifying drug delivery systems (SNEDDS) of atazanavir in an attempt to circumvent such obstacles. Equilibrium solubility studies indicated the choice of peceol oil - acrysol EL135-capmul MCMC8 for formulating the SNEDDS. Ternary phase diagram constructed with surfactant (Acrysol EL135), co-surfactant (Capmul MCMC8) and oil (peceol oil) representing each apex of the triangle. The pharmacokinetics studies of SNEDDS formulation were investigated in wistar rats. The optimal formulation (F9) with best self-nanoemulsified and solubilization ability consisted of 20% (w/w) peceol oilas oil, 60% (w/w) acrysol EL135 as surfactant and 20% (w/w) capmul MCMC8 as cosurfactant. The formulation displayed maximum drug content of 99, 98% entrapment efficiency and drug release of >98% in 60 minutes. The particle size for the optimized formulation of SNEDDS (F9) was found to be 51.6 nm with PDI 0.468 and zeta potential of -20.6 mV. The formulation found to be stable after storage at accelerated conditions at 40 ± 2°C/75 ± 5% RH for a period of six months. The pharmacokinetic study in rats indicate that the Cmax of the SNEDDS 0.33 ± 1.73 ng/mL was significant (p < 0.05) as compared to the pure drug 0.091 ± 0.39 ng/mL. Tmax of both SNEDDS formulation and pure drug was 1.5 ± 0.53 and 3 ± 0.72 hours, respectively. The AUC indicated significant enhancement in the rate and extent of bioavailability by the SNEDDS formulation compared to pure drug. The studies, therefore, indicate the successful formulation development of SNEDDS with distinctly improved bioavailability of atazanavir.
Keywords:
Bioavailability; central composite design; in vitro/in vivo studies pharmacokinetic study; self-nanoemulsifying drug-delivery system.DOI
https://doi.org/10.25004/IJPSDR.2022.140620References
Albaidhani SF, Hussein AA. Preparation and evaluation of solid supersaturable self-nanoemulsifying drug delivery system of candesartan cilexetil. J of Phara Sci and Res. 2019;11(3):859-68.
Taha E, Ghorab D, Zaghloul AA. Bioavailability assessment of vitamin A self-nanoemulsified drug delivery systems in rats: a comparative study. Medical Principles and Practice. 2007;16(5):355-9.
Taupitz T, Dressman JB, Buchanan CM, Klein S. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole. European J of Pharm. and Biopharm.. 2013 ;83(3):378-87.
Zu Y, Wu W, Zhao X, Li Y, Wang W, Zhong C, Zhang Y, Zhao X. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique. Int J of Pharm. 2014 Aug 25;471(1-2):366-76.
Rashid R, Kim DW, Abid Mehmood Yousaf OM, ud Din F, Park JH, Yong CS, Oh YK, Youn YS, Kim JO, Choi HG. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe. Int J of nanomed. 2015;10:6147.
Dabhi M, Limbani M, Sheth N. Preparation and in vivo evaluation of self-nanoemulsifying drug delivery system (SNEDDS) containing ezetimibe. Current Nanosci. 2011;7(4):616-27.
Kim KS, Yang ES, Kim DS, Kim DW, Yoo HH, Yong CS, Youn YS, Oh KT, Jee JP, Kim JO, Jin SG. A novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for improved stability and oral bioavailability of an oily drug, 1-palmitoyl-2-linoleoyl-3-acetyl-racglycerol. Drug deliv. 2017;24(1):1018-25.
Benet LZ, Broccatelli F, Oprea TI. BDDCS applied to over 900 drugs. AAPS J 2011;13:519-47.
Fukushima K, Terasaka S, Haraya K, et al. Pharmaceutical approach to HIV protease inhibitor atazanavir for bioavailability enhancement based on solid dispersion system. Biol Pharm Bull 2007;30:733-8
Balkundi S, Nowacek AS, Veerubhotla RS, et al. Comparative manufacture and cell based delivery of antiretroviral nano formulations. Int J Nanomed.2011;6:3393-404
Simpson KN, Jones WJ, Rajagopalan R, Dietz B. Cost effectiveness of lopinavir/ ritonavir tablets compared with atazanavir plus Ritonavir in antiretroviral experienced patients in the UK, France, Italy and Spain. Clin Drug Investig. 2007;27:807-17.
Zhang P, Liu Y, Feng N, Xu J. 2008. Preparation and evaluation of selfmicroemulsifying drug delivery system of oridonin. Int J Pharm. 2008;355:269–276.
Archana, G. &Raju, P.N. & Reddy, G.N.Formulation and invitro evaluation of Azatanavir oral disintegrating tablets. Asian J of Pharm and Clinical Res. 2014;7:184-188.
Czajkowska-Kośnik, A , S zekalska M , A melian A , S zymańska E , Winnick, K. Development and Evaluation of Liquid and Solid Self-Emulsifying Drug Delivery Systems for Atorvastatin. Molecules. 2015; 20(12): 21010–21022.
Shiva Kumar Mantri, ShailajaPashikanti, Ramana Murthy. Development and Characterization of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) of Atorvastatin Calcium.Current Drug Deliv. 2012; 9:182.
Bandivadekar MM, Pancholi SS, Shelke N. Preparation and characterization of solid SMEDDS by adsorbent techniques to improve dissolution profile of poorly aqueous soluble drug Ramipril. Int Res J of Pharm. 2011; 2(6):85-90.
Bandivadekar MM, Pancholi SS, Shelke N. Preparation and characterization of solid SMEDDS by adsorbent techniques to improve dissolution profile of poorly aqueous soluble drug Ramipril. Int Res J of Pharm. 2011; 2(6):85-90.
Khoo SM, Humberstone AJ, Porter CJ, Edwards GA, CharmanWN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J of pharm 1998;167:155-64.
Pouton CW. Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int J Pharm 1985; 27:335-348.
Nair R, Kumar AC, Priya VK. Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine. Lipids Health Dis. 2012;11: 72.
Duangkamon Sakloetsakun, Sarah Dünnhaupt, Jan Barthelmes, GlenPerera, AndreasBernkop-Schnürch Combining two technologies: multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration.Int J BiolMacromol. 2013 ; 61: 363–372.
Jeevana JB, Sreelakshmi K. Design and evaluation of selfnanoemulsifying drug delivery system of flutamide. J Young Pharm. 2011;3(1):4-8.
SellappanV and Mohamed A. Development and evaluation of Ritonavir mucoadhesive microspheres. Asian J of Pharma Clinical Res. 2014; 7(5): 47-52.
Elshafeey A, Bendas E, Mohamed O. Intranasal microemulsion of sildenafil citrate: in vitro evaluation and in vivo pharmacokinetic study in rabbits. AAPS Pharm Sci Tech. 2009;10(2):361–367.
Jinjie Zhang, Qiang Peng, sanjun shi1 Qiang Zhang, Xun sun, Taogong1 Zhirong Zhang, Preparation, characterization, and in vivo evaluation of a self-nano emulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex. Int J of Nanomed. 2011: 3405- 16.
Srinivasu K, Rao J, Raju N. Khagga M. A Validated RP-HPLC Method for the Determination of Atazanavir in Pharmaceutical Dosage Form. J of Chem.2011; 8.
Published
Abstract Display: 319 
PDF Downloads: 331 
